Stephanie Stewart, NP
Gerontology · Columbus, GANPI 1134630585
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 357 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.0% of the total. Among gerontology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 357 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$862
- Lilly USA, LLC$774
- Bayer$499
- AstraZeneca$381
- Boehringer Ingelheim$249
- plus $1K from 22 others
What the payments were for
- Food & beverage$5,668100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $1,531 |
| Novo Nordisk | 65 | $862 |
| Lilly USA, LLC | 54 | $774 |
| Bayer | 31 | $499 |
| AstraZeneca | 22 | $381 |
| Boehringer Ingelheim | 14 | $249 |
| Pfizer | 13 | $239 |
| Astellas Pharma US Inc | 7 | $132 |
| GSK | 7 | $112 |
| Ardelyx, Inc. | 5 | $104 |
| Esperion Therapeutics, Inc. | 4 | $87 |
| Daiichi Sankyo Inc. | 4 | $82 |
| Amgen | 5 | $79 |
| Exact Sciences | 4 | $76 |
| Inspire Medical Systems, Inc. | 1 | $60 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Abbott | 2 | $53 |
| Antares Pharma, Inc. | 2 | $43 |
| Johnson & Johnson | 2 | $39 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Eisai Inc. | 2 | $37 |
| Radius Health, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $28 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Halozyme Inc | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$5,675 in reported general payments places this provider in the 90th percentile of 197 gerontology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 43 | $57,802 |
| RybelsusSemaglutide | 23 | $32,296 |
| OzempicSemaglutide | 27 | $31,643 |
| EliquisApixaban | 18 | $28,092 |
| MounjaroTirzepatide | 13 | $24,042 |
| TradjentaLinagliptin | 14 | $17,576 |
| TrulicityDulaglutide | 11 | $15,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $13,781 |
| Nurtec OdtRimegepant Sulfate | 11 | $10,656 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $6,564 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,081 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,031 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $3,764 |
| BreynaBudesonide/Formoterol Fumarate | 15 | $2,638 |
| Olanzapine | 27 | $2,061 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $249 | $81,94271 claims |
| Novo NordiskRybelsus, Ozempic | $862 | $63,93850 claims |
| Lilly USA, LLCMounjaro, Trulicity, Olanzapine | $774 | $41,76951 claims |
| PfizerEliquis, Nurtec Odt | $239 | $38,74929 claims |
| GSKTrelegy Ellipta | $112 | $13,78115 claims |
| AstraZenecaSymbicort | $381 | $4,03113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 197 gerontology providers in Georgia.
Other gerontology in Columbus
- Laurel ArmstrongColumbus$4K
- Courtney HawkinsColumbus$4K
- Judith GoggansColumbus$2K
- Shandra GrimesColumbus$2K
- Carolyn ClevengerAtlanta$65K
- Mitzi LewisAtlanta$37K
- Constance MeinkenAtlanta$36K
- Britni JohnsonSavannah$24K
- Doreen AbrigoWarner Robins$14K
- Taylor SwineaWaycross$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.